Lucia Masarova
MD
Assistant Professor, Department of Leukemia
👥Biography 个人简介
Lucia Masarova is an emerging MPN expert at MD Anderson whose clinical research focuses on combination strategies to achieve deeper molecular responses in myelofibrosis. She has contributed to pivotal trials evaluating navitoclax (BCL-XL/BCL-2 inhibitor) in combination with ruxolitinib for myelofibrosis, including the TRANSFORM-1 trial. Her work explores whether navitoclax combinations can achieve clonal reduction and disease modification beyond symptom control. She actively investigates biomarkers predicting response to these novel combinations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Lucia Masarova 的研究动态
Follow Lucia Masarova's research updates
留下邮箱，当我们发布与 Lucia Masarova（University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment